Terms: = Prostate cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846
103 results:
1. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Li ZM; Liang ZH; Liu N; Wei KR
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
[No Abstract] [Full Text] [Related]
2. Smoking, Drinking, and Dietary Risk Factors for Head and Neck cancer in prostate, Lung, Colorectal, and Ovarian cancer Screening Trial Participants.
Lander DP; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):249-256. PubMed ID: 38329760
[TBL] [Abstract] [Full Text] [Related]
3. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract] [Full Text] [Related]
4. Data-driven strategies for increasing patient diversity in Bristol Myers Squibb-sponsored US oncology clinical trials.
Kuri L; Setru S; Liu G; Reed DM; Weigand D; Surampudi A; Berger S; Paulucci D; Rai A; Sethuraman V; Vito B; Kellar-Wood H; Balan MM
Clin Trials; 2023 Dec; 20(6):585-593. PubMed ID: 37309819
[TBL] [Abstract] [Full Text] [Related]
5. Incidence, predictors, and outcomes of febrile neutropenia and neutropenia in patients with metastatic castrate-resistant prostate cancer receiving docetaxel.
Peltekian S; Sajwani S; Wang X; Kanji S
Support Care Cancer; 2023 May; 31(5):311. PubMed ID: 37126153
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence of Shared Decision-making in prostate cancer Screening in New York State.
Mattick LJ; Biney K; Dacus HM; O'Sullivan GM; Ochs-Balcom HM
J Immigr Minor Health; 2023 Oct; 25(5):1207-1210. PubMed ID: 37084018
[TBL] [Abstract] [Full Text] [Related]
7. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
[TBL] [Abstract] [Full Text] [Related]
8. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
[TBL] [Abstract] [Full Text] [Related]
9. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden.
Balabanova Y; Farahmand B; Garmo H; Stattin P; Brobert G
BMJ Open; 2022 May; 12(5):e055485. PubMed ID: 35606159
[TBL] [Abstract] [Full Text] [Related]
10. Differential effect of body mass index (BMI) on outcomes of patients treated with docetaxel in prostate cancer - An exploratory analysis.
Verma S; Arora S; Sahoo RK; Singh P; Nayak B; Haresh KP; Das CJ; Shamim SA; Kaushal S; Batra A
Cancer Treat Res Commun; 2022; 31():100520. PubMed ID: 35091358
[TBL] [Abstract] [Full Text] [Related]
11. The Role of Pentraxin-3, Fetuin-A and Sirtuin-7 in the Diagnosis of prostate cancer.
Güzel Ö; Kösem A; Aslan Y; Asfuroglu A; Balci M; Senel C; Tuncel A
Urol J; 2021 Oct; 19(3):196-201. PubMed ID: 34655076
[TBL] [Abstract] [Full Text] [Related]
12. Out-of-pocket costs for commercially insured patients with localized prostate cancer.
Wallis CJD; Joyce DD; Klaassen Z; Luckenbaugh AN; Laviana AA; Penson D; Dusetzina SB; Barocas DA
Urol Oncol; 2021 Dec; 39(12):797-805. PubMed ID: 34600803
[TBL] [Abstract] [Full Text] [Related]
13. Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical prostatectomy when Grade and/or Stage Increase.
Altok M; Chapin BF; Matin SF; Achim MF; Gregg JR; Davis JW
Urology; 2021 Sep; 155():144-151. PubMed ID: 33676955
[TBL] [Abstract] [Full Text] [Related]
14. [Guidance of magnetic resonance imaging for target area delineation of postoperative presacral recurrence of rectal cancer].
Li XN; Liu T; Wang C; Guo P; Ye YJ; Chen YL; Cheng J
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1170-1176. PubMed ID: 33353272
[No Abstract] [Full Text] [Related]
15. Apalutamide for metastatic, castration-sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double-blind, placebo-controlled phase 3 TITAN study.
Uemura H; Arai G; Uemura H; Suzuki H; Iijima K; Nishimura K; Fujii K; Hatayama T; Aoyama J; Deprince K; Lopez-Gitlitz A; McCarthy S; Larsen JS; Li J; Chi KN
Int J Urol; 2021 Mar; 28(3):280-287. PubMed ID: 33295007
[TBL] [Abstract] [Full Text] [Related]
16. Trends in prostatectomy utilization: Increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer.
Kaps B; Leapman M; An Y
Cancer Med; 2020 Dec; 9(23):8754-8764. PubMed ID: 33128858
[TBL] [Abstract] [Full Text] [Related]
17. 'One Stop prostate Clinic': prospective analysis of 1000 men attending a public same-day prostate cancer assessment and/or diagnostic clinic.
Hawks C; Moe A; McCombie S; Hamid A; Brown M; Hayne D
ANZ J Surg; 2021 Apr; 91(4):558-564. PubMed ID: 32975001
[TBL] [Abstract] [Full Text] [Related]
18. Pelvic lymph-node staging with
Jansen BHE; Bodar YJL; Zwezerijnen GJC; Meijer D; van der Voorn JP; Nieuwenhuijzen JA; Wondergem M; Roeleveld TA; Boellaard R; Hoekstra OS; van Moorselaar RJA; Oprea-Lager DE; Vis AN
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):509-520. PubMed ID: 32789599
[TBL] [Abstract] [Full Text] [Related]
19. Radical prostatectomy Without Pelvic Lymph Node Dissection Is Widely Practiced in High-Risk Patients Despite Poorer Survival.
Kodiyan J; Guirguis A; Ashamalla H
Clin Genitourin Cancer; 2020 Oct; 18(5):395-401.e8. PubMed ID: 32409155
[TBL] [Abstract] [Full Text] [Related]
20. Sex After prostate cancer in Gay and Bisexual Men: A Review of the Literature.
McInnis MK; Pukall CF
Sex Med Rev; 2020 Jul; 8(3):466-472. PubMed ID: 32169431
[TBL] [Abstract] [Full Text] [Related]
[Next]
